Grey Cloak Financials
| HYEX Stock | USD 1.44 0.06 4.35% |
With this module, you can analyze Grey financials for your investing period. You should be able to track the changes in Grey Cloak individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Grey |
Understanding current and past Grey Cloak Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Grey Cloak's financial statements are interrelated, with each one affecting the others. For example, an increase in Grey Cloak's assets may result in an increase in income on the income statement.
The data published in Grey Cloak's official financial statements typically reflect Grey Cloak's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Grey Cloak's quantitative information. For example, before you start analyzing numbers published by Grey accountants, it's essential to understand Grey Cloak's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in Grey Cloak's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Grey Cloak Tech. Check Grey Cloak's Beneish M Score to see the likelihood of Grey Cloak's management manipulating its earnings.
Grey Cloak Stock Summary
Grey Cloak competes with Cannara Biotech. Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado. Healthy Extracts is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US42227D1000 |
| Business Address | 1 Silvermound, Littleton, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | healthyextractsinc.com |
| Phone | 702 463 1004 |
| Currency | USD - US Dollar |
Grey Cloak Key Financial Ratios
Grey Cloak's financial ratios allow both analysts and investors to convert raw data from Grey Cloak's financial statements into concise, actionable information that can be used to evaluate the performance of Grey Cloak over time and compare it to other companies across industries.| Return On Equity | -0.35 | |||
| Return On Asset | -0.27 | |||
| Beta | 2.03 | |||
| Z Score | 18.6 |
Grey Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grey Cloak's current stock value. Our valuation model uses many indicators to compare Grey Cloak value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grey Cloak competition to find correlations between indicators driving Grey Cloak's intrinsic value. More Info.Grey Cloak Tech is rated # 3 in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Grey Cloak by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Grey Cloak's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Grey Cloak Tech Systematic Risk
Grey Cloak's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Grey Cloak volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Grey Cloak Tech correlated with the market. If Beta is less than 0 Grey Cloak generally moves in the opposite direction as compared to the market. If Grey Cloak Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Grey Cloak Tech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Grey Cloak is generally in the same direction as the market. If Beta > 1 Grey Cloak moves generally in the same direction as, but more than the movement of the benchmark.
Grey Cloak March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Grey Cloak help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Grey Cloak Tech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Grey Cloak Tech based on widely used predictive technical indicators. In general, we focus on analyzing Grey OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Grey Cloak's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 57.45 | |||
| Value At Risk | (8.00) |
Additional Tools for Grey OTC Stock Analysis
When running Grey Cloak's price analysis, check to measure Grey Cloak's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grey Cloak is operating at the current time. Most of Grey Cloak's value examination focuses on studying past and present price action to predict the probability of Grey Cloak's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grey Cloak's price. Additionally, you may evaluate how the addition of Grey Cloak to your portfolios can decrease your overall portfolio volatility.